Val-083,烷化剂

VAL-083 (订货以英文为准)

编号:V125883
CAS号:23261-20-3
分子式:C6H10O4
分子量:146.14
货号 品牌 包装 目录价 您的价格 库存 数量 购买
V125883-10mg 阿拉丁 10mg ¥2070.90
V125883-5mg 阿拉丁 5mg ¥1610.90
V125883-50mg 阿拉丁 50mg ¥5560.90
V125883-1mg 阿拉丁 1mg ¥647.90
V125883-25mg 阿拉丁 25mg ¥3706.90
产品名称 VAL-083
中文名称 Val-083,烷化剂
CAS号 23261-20-3
分子式(M.F.) C6H10O4
分子量(M.W.) 146.14
储存条件 -20°C储存
溶解性25°C: DMSO
存贮条件储存温度-20°C
生化机理Description: IC50 Value: 5uM (inhibit U251, SF188, T98G cell growth in monolayer after 72h) VAL-083 surpasses temozolomide (TMZ) activity and inhibits cancer stem cells (CSCs) providing a new potential treatment option for glioblastoma multiforme (GBM). VAL-083 inhibited U251 and SF188 cell growth in monolayer better than TMZ and caused apoptosis [1]. in vitro: VAL-083 inhibited U251 and SF188 cell growth in monolayer and as neurospheres better than TMZ and caused apoptosis after 72 hr. In the colony formation assay, VAL-083 (5 uM) suppressed SF188 growth by about 95%. T98G cells are classically TMZ-resistant and express MGMT, but VAL-083 inhibited their growth in monolayer after 72 hr in a dose-dependent manner (IC50, 5 uM). VAL-083 also inhibited the growth of CSCs (BT74, GBM4, and GBM8) by 80-100% in neurosphere self-renewal assays. Conversely, there was minimal effect on normal human neural stem cells [1]. in vivo: N/A Clinical trial: Safety Study of VAL-083 in Pat
别名;Dianhydrodulcitol;Dianhydrogalactitol;VAL083
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:502-65-8
¥ 379.90 L1452550-5g
¥ 240.00 C416-01
¥ 240.00 C415-01
¥ 989.00 R0581S-200units
CAS号:2319-84-8
¥ 150.00 BD151508-1g